MECURE INDUSTRIES PLC

MECURE INDUSTRIES PLC was incorporated on March 16, 2005, and commenced its operations on August 17, 2005, establishing itself as a significant force within Nigeria's pharmaceutical sector. The company's foundational mission centers on pioneering the local production and distribution of high-quality, affordable healthcare solutions. Over time, it has evolved to address critical healthcare needs by emphasizing accessibility, innovation, and quality in its offerings. MECURE INDUSTRIES operates as a key member of the broader Mecure Group, which includes sister companies such as Mecure Healthcare Limited, focused on diagnostics, Mecure Infraproject Limited, Mecure Smart Buy Limited, and Mecure Wecare Limited, fostering a synergistic approach to healthcare services. The company's core business revolves around the manufacturing of a diverse range of pharmaceutical products, primarily tablets, capsules, and syrups, categorizing its offerings into Pharmaceuticals and Nutraceuticals. Its product portfolio encompasses medications for acute and chronic ailments, including branded generics like ibuprofen (Ebu 200 & 400), ampiclox (Laclox), amoxicillin (Lamox), and ampicillin (Lampicin). The nutraceuticals segment features a wide array of products, including multivitamins and dietary supplements, with notable brands such as Zevit. MECURE INDUSTRIES serves the Nigerian market extensively through a robust distribution network, including four strategically located depots and over 100 distributors, extending its reach across Nigeria and into the wider West African region. Additionally, it offers Contract Manufacturing and Contract Research Organization (CRO) services, leveraging state-of-the-art facilities and expertise to support pharmaceutical research and development and produce formulations for other entities.